Adding a second HER2 blocker may lower chance of invasive breast cancer for some women - Science Daily

Adding a second HER2 blocker may lower chance of invasive breast cancer for some women Science Daily While the prognosis for patients who receive standard of care trastuzumab is already favorable, patients in the study who received pertuzumab and trastuzumab had a 19% lower chance of developing invasive breast cancer than those who received ... and more »

from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2vNWhdn
via IFTTT